# An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

> **NCT01406119** · PHASE1 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 14 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** ABT-806

## Key facts

- **NCT ID:** NCT01406119
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406119, "An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01406119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*